If anyone wants to object to the scheme now is the time.
If I had the time I would give it a go but unfortunately I haven't.
I could find several reasons to object to the scheme;
- shareholders not provided up to date information of how SGH is currently going
- $1billion lawsuit was not properly mentioned in the explanatory notes
- NIHL which is outside the balance sheet was not properly mentioned in the explanatory notes
- incorrect valuation method was used (they should have used the discounted cash flow method which uses future earnings and not historical earnings which is to the benefit of AC)
- much more.
If you want to object go for it. It is now and not later it is happening.
Here is a link as to what the courts are looking at
https://www.lavan.com.au/advice/rec...restructuring_through_a_scheme_of_arrangement
SWC![]()
- Forums
- ASX - By Stock
- SGH
- Object to the scheme
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

Object to the scheme
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
2 | 443 | 51.130 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 350 | 51.000 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 1043 | 5 |
51.520 | 736 | 1 |
51.550 | 487 | 2 |
51.580 | 512 | 1 |
51.590 | 445 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online